Correlation Between 23Andme Holding and Aileron Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Aileron Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Aileron Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Aileron Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and Aileron Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Aileron Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Aileron Therapeutics.
Diversification Opportunities for 23Andme Holding and Aileron Therapeutics
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and Aileron is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Aileron Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aileron Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Aileron Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aileron Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Aileron Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and Aileron Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Aileron Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, 23Andme Holding Co is 1.44 times less risky than Aileron Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Aileron Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 255.00 in Aileron Therapeutics on September 25, 2024 and sell it today you would lose (68.00) from holding Aileron Therapeutics or give up 26.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 99.8% |
Values | Daily Returns |
23Andme Holding Co vs. Aileron Therapeutics
Performance |
Timeline |
23Andme Holding |
Aileron Therapeutics |
23Andme Holding and Aileron Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 23Andme Holding and Aileron Therapeutics
The main advantage of trading using opposite 23Andme Holding and Aileron Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Aileron Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aileron Therapeutics will offset losses from the drop in Aileron Therapeutics' long position.23Andme Holding vs. Fate Therapeutics | 23Andme Holding vs. Caribou Biosciences | 23Andme Holding vs. Arcus Biosciences | 23Andme Holding vs. Karyopharm Therapeutics |
Aileron Therapeutics vs. Bio Path Holdings | Aileron Therapeutics vs. Benitec Biopharma Ltd | Aileron Therapeutics vs. Artelo Biosciences | Aileron Therapeutics vs. Histogen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |